This document provides guidance on obstetric history taking and examination. It discusses obtaining a detailed personal, medical, surgical, obstetric and family history from the patient. Physical examination involves inspection of general appearance and vital signs, examination of breasts, abdomen, pelvis and fetal assessment. The abdominal examination includes assessing fetal position, presentation and growth. The vaginal examination evaluates cervical dilation and effacement to determine Bishop score for labor readiness. Obtaining a thorough history and physical examination is important for diagnosing any complications, determining gestational age and developing a provisional diagnosis and management plan.
Prenatal Assessment of Gestational Age - Case Presentation Nawras AlHalabi
Prenatal Assessment of Gestational Age - Case Presentation
تقدير عمل الحمل، حالة سريرية.
Faculty of Medicine of Syrian Private University
كليّة الطّبّ البشريّ في الجامعة السّوريّة الخاصّة
20-12-2015
Prenatal Assessment of Gestational Age - Case Presentation Nawras AlHalabi
Prenatal Assessment of Gestational Age - Case Presentation
تقدير عمل الحمل، حالة سريرية.
Faculty of Medicine of Syrian Private University
كليّة الطّبّ البشريّ في الجامعة السّوريّة الخاصّة
20-12-2015
post term pregnancy, post dated pregnancy, prolonged pregnancy,
m.g. reshmi, management of post dated pregnancy,management of post term pregnancy, fetal maturity assesment, post maturity syndrome, mortality and morbidity ,placental dysfunction, aminotic fluid volume in prolonged pregnancy.
post term pregnancy, post dated pregnancy, prolonged pregnancy,
m.g. reshmi, management of post dated pregnancy,management of post term pregnancy, fetal maturity assesment, post maturity syndrome, mortality and morbidity ,placental dysfunction, aminotic fluid volume in prolonged pregnancy.
History and Examination in OBGYN Skill lab.pdfElhadi Miskeen
By the end of this presentation, students :
1. Should be able to refine communication and clinical care skills in taking a pertinent comprehensive medical history
2. Assessing risk and patient adherence to health care recommendations.
3. Should be able to use this information to formulate a diagnosis and management plan while communicating important findings and recommendations to the patient
incorporating her socioeconomic and cultural context
Failure to thrive in neonates and infants + pediatric case.pptxclaviclebrown44
Hello, I’m Dr. Mariam Abayomi, an Intern doctor in Jamaica, passionate about promoting health and wellbeing. I invite you to explore my latest presentation on Failure to Thrive (FTT), a condition that can significantly impact a child’s growth and development.
In this presentation, you'll learn about:
- Understanding FTT: What is Failure to Thrive? We’ll break down the medical definition, common causes, and symptoms to watch for.
- Case Study Insight: Meet [Child’s Name], a [age]-month-old who struggled with FTT. Through their story, we’ll explore the real-life application of diagnosing and managing this condition.
- Diagnostic Approaches: From growth charts to lab tests, discover the essential tools and methods used to identify FTT.
- Management and Treatment: Learn about the multidisciplinary strategies employed to help children with FTT thrive, including nutritional support, medical treatments, and family education.
- Key Takeaways: Highlighting the importance of early detection, comprehensive care, and ongoing monitoring to ensure the best outcomes for children.
By following me on social media @HealthInspire, you’ll get updates, tips, and insights into health and wellbeing. Whether you’re a healthcare professional, a student, or a parent, my goal is to provide you with reliable information, support, and a bit of humor to navigate the world of health and wellness.
Join me in making a difference – one informed decision at a time. Let's inspire better health together!
Ahmed Walid Anwar Morad; Peripartum Cardiomyopathy: The European Society of Cardiology classifies PPCM as a nonfamilial, nongenetic, idiopathic form of dilated CM.
Ahmed Walid Anwar Morad, Professor Obstetrics and Gynecology
Optional procedures alongside the standard IVF protocol to increase the chance of a live birth.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
2. Key points
Introduce yourself using the full name .
Explain what would you like to do and gain her consent.
Ensure the patient is comfortable and warm.
Do not do vaginal or breast exam. alone.
All information's are confidential.
3. APPROACH TO AN OBSTETRIC PATIENT
HISTORY
EXAMINATION
INVESTIGATIONS
4. HISTORY
History taking is an ART :
- Logical sequence
- Avoid inadvertent omission of important details.
- Guide examination.
Since pregnancy is a “normal” occurrence, the usual
format of the clinical history should be modified.
History of past pregnancy may alter the outcome of
current pregnancy.
5. 1-Personal History
NN→ Name→ Name
AA→ Age→ Age
SS→→ sexsex XXXXXXXXXXXXXXXXXXXXXXXXXX
OO → Occupation→ Occupation
MM→ Marital status→ Marital status
RR→ Residency (Address)→ Residency (Address)
HH→ Special Habits→ Special Habits
GG→→ Gravidity
P→ Parity
6. Terminology
Gravida x, para a+ b
x = total number of pregnancies including this one
a = number of births beyond 24 weeks
b= number of pregnancies terminated befor 24 weeks
7. 22--CHIEF COMPLAINTSCHIEF COMPLAINTS
Chief complaint withChief complaint with
durationduration inin chronological orderchronological order
in patientin patient own wordsown words
8. 33--HISTORY OF PRESENT ILLNESSHISTORY OF PRESENT ILLNESS
1.1. AMENORRHOEA:AMENORRHOEA:
Expressed in weeks, Calculated from LMPExpressed in weeks, Calculated from LMP
Diagnosis of pregnancy confirmed???Diagnosis of pregnancy confirmed???
DATINGDATING
(EDD= LMP +9M+7D)
For accurate estimation:
- Menses – regular, average length, sure
- No recent use of COC pills.
Obstetric calendar (wheel)
First trimester ultrasound scan
Later ultrasound scan
10. 33--HISTORY OF PRESENT ILLNESSHISTORY OF PRESENT ILLNESS
2.2. SYMPTOMS RELATED TO PREGNANCY:SYMPTOMS RELATED TO PREGNANCY:
NAUSEA & VOMITING
FREQUENCY OF MICTURATION
CONSTIPATION
HEAVINESS IN THE BREAST
RISE OF TEMPERATURE
3. ANKLE OEDEMA:ANKLE OEDEMA:
PRESSURE DUE TO GRAVID UTERUS
? HTN, ??? Protein Urea
11. 33--HISTORY OF PRESENT ILLNESSHISTORY OF PRESENT ILLNESS
4.4. PAIN ABDOMEN:PAIN ABDOMEN:
LABOUR PAIN
ABRUPTIO PLACENTAE
PRE-ECLAMPSIA TOXEMIA
DEGENERATION OF MYOMA
ACUTE URINARY RETENSION
TORSION OF OVARIAN CYST
ACUTE CHOLECYSTITISACUTE CHOLECYSTITIS
12. 33--HISTORY OF PRESENT ILLNESSHISTORY OF PRESENT ILLNESS
5.5.BACKACHE:BACKACHE:
Increase in body weight
Hyperextension of the spine
Laxity of joints in pelvis and spine
6. VAGINAL BLEEDING:6. VAGINAL BLEEDING:
- Implantation Hemorrhage,- Implantation Hemorrhage,
- Early pregnancy : Abortion, Ectopic Pregnancy, V.mole,- Early pregnancy : Abortion, Ectopic Pregnancy, V.mole,
- Late pregnancy: Placenta Previa, Abruptio Placenta, Vasa previa- Late pregnancy: Placenta Previa, Abruptio Placenta, Vasa previa
13. 33--HISTORY OF PRESENT ILLNESSHISTORY OF PRESENT ILLNESS
7.7. Decreased FETAL MOVEMENT:Decreased FETAL MOVEMENT: 10/ 12 hrs10/ 12 hrs
PRIMI: 18 weeks
MULTI: 16 weeks
8..Excessive ENLARGEMENT OF THE ABDOMEN:Excessive ENLARGEMENT OF THE ABDOMEN:
Multiple pregnancy ,
Hydramnios,
accidental hemorrhage,
Macrocosmia,
Miscalculation.
14. 33--HISTORY OF PRESENT ILLNESSHISTORY OF PRESENT ILLNESS
9.9.VAGINAL DISCHARGEVAGINAL DISCHARGE::
RUPTURE OF MEMBRANE
PHYSIOLOGICAL LEUCORRHOEA
CANDIDIASIS
CERVICITIS
10. HISTORY OF TT/ IRON+ CA SUPPLIMENTHISTORY OF TT/ IRON+ CA SUPPLIMENT
15. 3-HISTORY OF PRESENT ILLNESS
Pregnant female for ( weeks) as her LNMP ( / / ) and EDD ( / / ) and
pregnancy is confirmed by pregnancy test since( / / )
Analysis of the complaint ( onset, course duration)
History of current pregnancy
details of the 1st
,2nd
& 3rd
trimester
admission and examination
Investigations : lab tests & U/S scans pattern
the expected management
System review ( (
16. 4-Menstrual & gynecological history
Cycle :
- 1st
day of LNMP ( was it conform to the usual in terms of
timing, volume, and appearance)
- Regularity
- Length
- OCP use.
Surgical procedures
Hx of infertility
Sexually transmitted diseases
Uterine anomalies
17. 5-Past obstetric history
Gravidity, Parity
Outcomes
Gestational age: abortion, preterm, term
Delivery
Date
Mode
Place
Infant : sex ,weight, wellbeing
Complications
18. 6-Past medical/ surgical H
- Some medical conditions may have impact on the course of
the pregnancy or the pregnancy may have an impact on the
medical condition examples:
Heart disease
Hypertension
Dm
Epilepsy
Thyroid disease
B asthma
Any previous surgery.
Kidney disease
UTI
Autoimmune disease
Psychiatric disorders
Hepatitis
Venereal diseases
Blood transfusion
19. OBSTETRIC HISTORY
7- Drug history and allergy.
8- Social Hx → Cigarette smoking, illegal drug use, domestic
violence, psychiatric illness specially in postnatal period.
9- Family Hx
- Hereditary illness → DM., Hpt., thalassemia, sickle cell
disease, hemophilia
-Congenital defects eg. neural tube defects, Down
syndrome
-Twins
21. Key points
Wash your hands
Introduce yourself using the full name .
Explain what would you like to do and gain her consent.
Ask patient to empty the bladder .
Do not do vaginal or breast exam. alone.
Ensure the patient is comfortable and warm.
22. Key points
For abdominal exam: Uncover the patient’s abdomen
from the xiphi sternum to the pubic hairline, .
Abdominal wall relaxation is maximized by (arms
along side and hips slightly flexed)
Advise the mother to indicate if she should feel weak
or nauseous.
All information's are confidential.
23. EXAMINATION
General
General of the general
Local of the general
Breast
Chest
Abdominal
Heart
Back
Lower limbs
Specific
Abdominal ( ???)
Pelvic
24.
25. General exam
GENERAL PHYSICAL EXAMINATION :GENERAL PHYSICAL EXAMINATION :
APPEARANCE, HEIGHT, WEIGHT ,Body Mass IndexAPPEARANCE, HEIGHT, WEIGHT ,Body Mass Index
MODE, MEMORY, INTELEGENCE,MODE, MEMORY, INTELEGENCE,
ORINTATION (TIME ,PLACE AND PERSONS)ORINTATION (TIME ,PLACE AND PERSONS)
GAITGAIT
DECUBETUS , chloasmaDECUBETUS , chloasma
Head, eyes, ears, nose & throatHead, eyes, ears, nose & throat → no changesno changes
ThyroidThyroid → diffuse enlargementdiffuse enlargement
PALLOR, ICTERUS, LYMPH NODES, CYANOSIS,PALLOR, ICTERUS, LYMPH NODES, CYANOSIS,
CLUBBING, OEDEMA, DEHYDRATIONCLUBBING, OEDEMA, DEHYDRATION
26. General exam
VITAL SIGNS :VITAL SIGNS :
PULSEPULSE
BLOOD PRESSUREBLOOD PRESSURE
RESPIRATORY RATERESPIRATORY RATE
TEMPERATURETEMPERATURE
BREAST EXAMINATIONBREAST EXAMINATION
Chest ,heartChest ,heart
Ophthalmoscopy hypertensive /diabetic women
27. Blood pressure
Blood pressure: seated, semi-recombent.
each visit.
HTN : BP > 140/90 mm Hg on 2 separate
occasions 6 H apart and less than 7 days using 5th
Korotkoff sounds .
< 20 wks Chronic HTN .
> 20 wks Gestational HTN.
PET.
28. Abdominal exam
Semi-recumbent position.
Cover legs with sheet.
Inspection:
- Shape of uterus .
- Any asymmetry.
- Look for fetal movements.
- Look for scars
- Hernia orifices.
- Cutaneous signs of pregnancy → linea nigra,
striae gravidarum, striae albicans, umbilicus flat or
everted, superficial veins
33. A), First maneuver. One or both hands are placed over fundus and the fetal part
identified.
(B), Second maneuver. The palmar surface of one hand is used to locate the back of
the fetus and the other hand to feel the irregularities, such as hands and feet.
(C), Third maneuver. Thumb and third finger are used to grasp presenting part over
the pubic symphysis.
(D), Fourth maneuver. Both hands are used to outline the fetal head.
34. Abdominal exam
3-Ascultation of fetal heart
*Site: anterior fetal shoulder .
*Time:
- 12 wks by sonicade ( US Doppler device)
- 24 wks by Pinard steoscope
* Duration: rate ,rhythm over 1 min.
4-Percussion polyhydramnious ballotment & fluid
thrill
35. Vaginal examination:
PRE-REQUISITS:PRE-REQUISITS:
EXPLANATIONEXPLANATION
EMPTY BLADDEREMPTY BLADDER
DORSAL POSITIONDORSAL POSITION
FULL ASEPSISFULL ASEPSIS
Equipment are presentEquipment are present
ContraindicationsContraindications ::
Placenta praevia.Placenta praevia.
Prelabour rupture ofPrelabour rupture of
membranesmembranes
36. Vaginal examination
Vulva and perineum:
Hyper pigmentation
Look for abnormalities Varicose veins/ hemorrhoids,
Warts or herpes
Cx : Softer, pigmented with thick , yellowish
mucous secretions
Uterus : enlarged
37. Pelvic assessment
Check ischial spines if prominent or not
Diagonal conjugate distance from lower border of the
symphysis pubis to the sacral promontery (pelvic inlet)
Shape of the sacrum
Side walls of the pelvis
Distance between the two sacral promonteries
39. Provisional Diagnosis
Name …….., age ……. y, Gx Pa+b , ………. Gestational weeks,
complains of………., most probably……….., complicated or not,
for further investigations and management.